BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 84 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $186,967 | -82.5% | 73,900 | +28.7% | 0.00% | -100.0% |
| Q1 2023 | $1,071,084 | +69.6% | 57,400 | +95.2% | 0.00% | +50.0% |
| Q4 2022 | $631,512 | -17.4% | 29,400 | -54.6% | 0.00% | 0.0% |
| Q3 2022 | $765,000 | -41.6% | 64,700 | -34.8% | 0.00% | -50.0% |
| Q2 2022 | $1,309,000 | +332.0% | 99,200 | +584.1% | 0.00% | +300.0% |
| Q1 2022 | $303,000 | +15.6% | 14,500 | +12.4% | 0.00% | 0.0% |
| Q4 2021 | $262,000 | -76.9% | 12,900 | -65.4% | 0.00% | -66.7% |
| Q3 2021 | $1,132,000 | -40.3% | 37,300 | -42.8% | 0.00% | -40.0% |
| Q2 2021 | $1,895,000 | -45.2% | 65,200 | -18.6% | 0.01% | -44.4% |
| Q1 2021 | $3,457,000 | +297.8% | 80,100 | +326.1% | 0.01% | +350.0% |
| Q4 2020 | $869,000 | -39.7% | 18,800 | -30.9% | 0.00% | -50.0% |
| Q2 2020 | $1,442,000 | – | 27,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LUMINUS MANAGEMENT LLC | 157,099 | $4,565,000 | 0.66% |
| ACT CAPITAL MANAGEMENT, LLC | 42,000 | $1,221,000 | 0.63% |
| Knoll Capital Management, LLC | 20,000 | $581,000 | 0.30% |
| Artemis Investment Management LLP | 1,193,290 | $34,664,000 | 0.30% |
| Ghisallo Capital Management LLC | 225,000 | $6,539,000 | 0.25% |
| Monashee Investment Management LLC | 60,000 | $1,744,000 | 0.21% |
| AlphaCentric Advisors LLC | 25,000 | $727,000 | 0.20% |
| CAAS CAPITAL MANAGEMENT LP | 232,285 | $6,750,000 | 0.11% |
| AllSquare Wealth Management LLC | 5,402 | $157,000 | 0.09% |
| CNA FINANCIAL CORP | 9,479 | $275,000 | 0.08% |